Premenstrual Syndrome: Appeareing in KEY Obstetrics and Gynecology 1991;4(4):31
Thirty patients completed treatment with danazol and 29 with placebo. Significantly greater improvement occurred with danazol. Breast discomfort, irritability, depression, anxiety, mood swings, crying, depressed libido, and abdominal swelling all were less evident with danazol than with placebo (Table 4). Menstrual change and nausea were more frequent with danazol, but there were no clinically serious side effects. Body weights were similar at the end of treatment.
Danazol lessens most of the common symptoms of PMS as well as the overall severity of the disorder. Significant androgenic changes did not occur in the present patients. The salutary effects of danazol in women with PMS do not depend on the occurrence of amenorrhea.
This well-designed placebo controlled trial indicates that a low dose of danzol, 100mg twice a day, was effective in relieving many of these patients' premenstrual symptoms. Menses continued in two-thirds of the patients, and clinical side effects were minimal with this low doage of danazol. It may be worthwhile to try this treatment for 6 months or so in some women with severe premenstrual symptoms who fail to respond to other treatments. D. R. Mishell, Hr., M.D.
|Breast discomfort||2.9||20.9||P < 0.01||P < 0.01|
|Irritability||6.9||22.1||P < 0.01||P < 0.01|
|Depression||2.9||12.9||P < 0.01||P < 0.01|
|Anxiety||3.8||12.9||P < 0.05||P < 0.05|
|Mood swings||1.8||12.6||P < 0.05||P < 0.01|
|Crying||1.8||5.0||not significant||not significant|
|Depressed libido||33.6||57||P < 0.01||P < 0.01|
|Headaches||4.3||9.7||not significant||not significant|
|Fluid Retention||4.3||4.4||not significant||P <0.01|
|Abdominal swelling||4.7||515.7||P < 0.01||P < 0.01|
|Increased appetite||3.3||3.4||not significant||not significant|
ns: P>= 0.05
[Courtsey of Deeny M, Hawthorn R, Hart DM: Postgrad Med J 1991;67:450-54
The materials within this website are copyrighted under the statutes of the State of Michigan. For additional copies contact:
office fax: 1(248)358-2513